Reem Hal/LinkedIn
Dec 25, 2025, 23:39
Reem Hal Shares New Clinical Capsule: Thrombosis in Cancer Patients
Reem Hal, Senior Pediatric Oncology Clinical Pharmacist at Borg El Arab Main University Hospital, shared a post on LinkedIn:
“Clinical Capsule | Oncology Rounds
Capsule #5 – Thrombosis in Cancer Patients
‘The cancer didn’t cause the ICU admission — the missed prophylaxis did.’
A patient with multiple myeloma on
lenalidomide + dexamethasone
missed thromboprophylaxis →
acute myocardial infarction. ICU admission.
Clinical Pearl
IMiD-based regimens dramatically increase thrombotic risk.
Standard practice
- Low risk → Aspirin
- High risk → LMWH or DOAC
Missed prophylaxis may lead to
- MI or stroke
- Treatment interruption
Take-home message
In multiple myeloma, thromboprophylaxis is not optional — it is life-saving.”
Follow the latest in Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation